APA (7th ed.) Citation

Duffy, F. H., D'Angelo, E., Rotenberg, A., & Gonzalez-Heydrich, J. (2015). Neurophysiological differences between patients clinically at high risk for schizophrenia and neurotypical controls--first steps in development of a biomarker. BMC Medicine, 13, 1. https://doi.org/10.1186/s12916-015-0516-z

Chicago Style (17th ed.) Citation

Duffy, Frank H., Eugene D'Angelo, Alexander Rotenberg, and Joseph Gonzalez-Heydrich. "Neurophysiological Differences Between Patients Clinically at High Risk for Schizophrenia and Neurotypical Controls--first Steps in Development of a Biomarker." BMC Medicine 13 (2015): 1. https://doi.org/10.1186/s12916-015-0516-z.

MLA (9th ed.) Citation

Duffy, Frank H., et al. "Neurophysiological Differences Between Patients Clinically at High Risk for Schizophrenia and Neurotypical Controls--first Steps in Development of a Biomarker." BMC Medicine, vol. 13, 2015, p. 1, https://doi.org/10.1186/s12916-015-0516-z.